Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Skye Bioscience, Inc.(SKYE) | 0 | 2,007,702 | +2,007,702 | 0 | 31,400 | 30.45% | +31,400 |
| Adverum Biotechnologies, Inc. | 5,068,233 | 506,822 | -4,561,411 | 3,815 | 7,166 | 6.95% | +3,351 |
| CRISPR Therapeutics AG(CRSP) | 498,558 | 498,558 | 0 | 31,210 | 33,982 | 32.95% | +2,772 |
| Gritstone Oncology, Inc. | 3,561,150 | 3,561,150 | 0 | 7,265 | 9,152 | 8.87% | +1,887 |
| Passage Bio, Inc.(PASG) | 4,959,769 | 4,959,769 | 0 | 5,009 | 6,696 | 6.49% | +1,686 |
| Aligos Therapeutics, Inc. | 2,320,381 | 2,320,381 | 0 | 1,541 | 2,274 | 2.20% | +733 |
| Repare Therapeutics, Inc. | 2,646,657 | 2,646,657 | 0 | 19,321 | 12,466 | 12.09% | -6,855 |
| RayzeBio, Inc. | 5,158,161 | 0 | -5,158,161 | 320,683 | 0 | — | -320,683 |